SecSonar.com

Pelthos Therapeutics Inc. (PTHS)

Pelthos Therapeutics Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Pelthos Therapeutics Inc. (PTHS) is a Biotechnology company based in US with a market capitalization of $17.2M. Free cash flow was negative at -$22.7M. This page tracks PTHS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 4 employees · IPO Jul 2, 2025

Valuation

Valuation & price

$26.72 · as of May 17, 2026 · -28.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.44

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$37.42$26.95$16.47Jul 25Dec 25Jul 26Jul 7, 25$25.95Jul 9, 25$16.47Jul 11, 25$18.32Jul 15, 25$21.13Jul 17, 25$22.13Jul 21, 25$19.84Jul 23, 25$21.87Jul 25, 25$21.99Jul 29, 25$22.01Jul 31, 25$21.15Aug 4, 25$21.00Aug 6, 25$20.02Aug 11, 25$19.00Aug 13, 25$18.18Aug 15, 25$20.96Aug 19, 25$20.51Aug 21, 25$21.45Aug 25, 25$22.59Aug 27, 25$23.72Aug 29, 25$23.65Sep 3, 25$27.80Sep 5, 25$28.22Sep 9, 25$31.57Sep 11, 25$32.00Sep 16, 25$32.02Sep 18, 25$33.31Sep 22, 25$33.16Sep 24, 25$33.88Sep 26, 25$33.80Sep 30, 25$28.00Oct 2, 25$26.62Oct 6, 25$28.25Oct 8, 25$27.14Oct 10, 25$23.26Oct 14, 25$26.83Oct 16, 25$28.50Oct 21, 25$31.00Oct 23, 25$34.65Oct 27, 25$32.00Oct 29, 25$32.50Oct 31, 25$33.00Nov 4, 25$34.75Nov 6, 25$37.42Nov 10, 25$34.00Nov 12, 25$37.40Nov 14, 25$33.61Nov 18, 25$31.83Nov 20, 25$29.00Nov 25, 25$27.11Nov 28, 25$28.40Dec 2, 25$25.14Dec 4, 25$26.36Dec 8, 25$27.13Dec 10, 25$25.03Dec 12, 25$22.99Dec 16, 25$21.83Dec 18, 25$22.67Dec 22, 25$26.76Dec 24, 25$26.50Dec 29, 25$27.20Jan 2, 26$29.45Jan 6, 26$27.44Jan 8, 26$28.06Jan 12, 26$25.55Jan 14, 26$25.10Jan 16, 26$23.06Jan 21, 26$23.03Jan 23, 26$24.75Jan 27, 26$25.89Jan 29, 26$25.78Feb 2, 26$25.30Feb 4, 26$23.31Feb 9, 26$22.08Feb 11, 26$22.06Feb 13, 26$20.58Feb 18, 26$19.60Feb 20, 26$23.24Feb 24, 26$23.24Feb 26, 26$23.00Mar 2, 26$24.16Mar 4, 26$23.01Mar 6, 26$23.12Mar 10, 26$25.31Mar 12, 26$23.25Mar 17, 26$23.85Mar 19, 26$22.97Mar 23, 26$22.00Mar 25, 26$22.09Mar 27, 26$22.49Mar 31, 26$21.01Apr 2, 26$20.40Apr 7, 26$22.74Apr 9, 26$22.58Apr 13, 26$23.00Apr 15, 26$23.00Apr 17, 26$23.02Apr 22, 26$23.00Apr 24, 26$23.06Apr 28, 26$24.97Apr 30, 26$25.00May 4, 26$24.82May 6, 26$25.00May 8, 26$25.50May 12, 26$27.24May 14, 26$27.69May 18, 26$26.15May 20, 26$27.11May 22, 26$26.66May 28, 26$25.80Jun 1, 26$26.20Jun 3, 26$25.88Jun 5, 26$25.55Jun 9, 26$26.90Jun 11, 26$28.72Jun 15, 26$26.50Jun 17, 26$27.01Jun 22, 26$29.28Jun 24, 26$28.71Jun 26, 26$29.03Jul 2, 26$25.77
$16.4752-week range$37.42
Loading valuation history…

Fundamentals

Key fundamentals

$17.2M

Market cap

—

Revenue growth (YoY)

62.6%

Gross margin

-$22.7M

Free cash flow (USD)

$16.8M

Net debt

220.0%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2020 → 2025

FY 2020$199.9KFY 2021$0.00FY 2022$0.00FY 2023$0.00FY 2024$0.00FY 2025$16.8M
$199.9K$16.8M

Free cash flow by year

2022 → 2025

FY 2022$-1.6MFY 2023$-981.0KFY 2024$-5.8MFY 2025$-22.7M
-$1.6M-$22.7M

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

6

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $-3.09)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $8K · 10b5-1 PlanFriedberg Ezra M · Director · $7.7KJun 17, 2026Filing
  • Insider buyInsider Buy $1000KDavis Todd C · Director · $1MJun 15, 2026Filing
  • 8-K eventInvestor Conference ParticipationMay 28, 2026Filing
  • Insider sellInsider Sell $40KFrancis Knuettel II · CFO, Treas & Secty · $40.3KMay 26, 2026Filing
  • 8-K eventEmployee TerminationMay 21, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • 8-K eventCorporate Presentation ReleasedApr 14, 2026Filing
  • 8-K eventCFO AppointmentApr 10, 2026Filing
  • Insider sellInsider Sell $17K · 10b5-1 PlanGreenleaf Peter · Director · $16.7KApr 6, 2026Filing

Questions

Frequently asked questions

What is Pelthos Therapeutics Inc.'s market cap?

Pelthos Therapeutics Inc. (PTHS) has a market capitalization of $17.2M.

What is PTHS's P/E ratio?

A meaningful P/E ratio is not available for PTHS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PTHS's price-to-book (P/B) ratio?

PTHS trades at 0.44 times book value per share.

When did Pelthos Therapeutics Inc. last report earnings?

PTHS last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying PTHS stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 6 sells at Pelthos Therapeutics Inc. in the last 90 days.

Same arena

Related companies in Biotechnology

MRKR

Marker Therapeutics, Inc.

$17M

APLM

Apollomics, Inc.

$16.5M

GRDX

GridAI Technologies Corp.

$18.4M

LGVN

Longeveron Inc.

$15.4M

PSTV

Plus Therapeutics, Inc.

$14.4M

SER

Serina Therapeutics, Inc.

$20M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.